about
Effects of Age on Na(+),K(+)-ATPase Expression in Human and Rodent Skeletal MuscleInsights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal ModelsParkinson's Disease: The Mitochondria-Iron LinkInsights into the Pathology of the α2-Na(+)/K(+)-ATPase in Neurological Disorders; Lessons from Animal Models.Managing Brain Extracellular K(+) during Neuronal Activity: The Physiological Role of the Na(+)/K(+)-ATPase Subunit IsoformsFaulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotypeCognitive deficits caused by a disease-mutation in the α3 Na(+)/K(+)-ATPase isoform.ATP1A3 Mutation in Adult Rapid-Onset AtaxiaTransgenic rescue of phenotypic deficits in a mouse model of alternating hemiplegia of childhood.Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseParkinson's disease: animal models and dopaminergic cell vulnerabilityMolecular mechanisms of epilepsyIn Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C. elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function DefectsNa, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF RegistryModeling mania in preclinical settings: A comprehensive review.Deficits in social behavioral tests in a mouse model of alternating hemiplegia of childhood.Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders.Hypothermia-induced dystonia and abnormal cerebellar activity in a mouse model with a single disease-mutation in the sodium-potassium pump.The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease.Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia.Spontaneously Fluctuating Motor Cortex Excitability in Alternating Hemiplegia of Childhood: A Transcranial Magnetic Stimulation Study.Intermediate Phenotypes of ATP1A3 Mutations: Phenotype-Genotype CorrelationsClinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood-a study of 155 patientsAberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism.Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPasePathway-driven discovery of epilepsy genes.Sodium pump organization in dendritic spines.De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis.Movement disorders in 2014. Genetic advances spark a revolution in dystonia phenotyping.P2C-Type ATPases and Their Regulation.The genetics of the dystonias--a review based on the new classification of the dystonias.A SINE Insertion in ATP1B2 in Belgian Shepherd Dogs Affected by Spongy Degeneration with Cerebellar Ataxia (SDCA2).Src-independent ERK signaling through the rat α3 isoform of Na/K-ATPase.Quantitative sodium MR imaging: A review of its evolving role in medicine.Diagnosis and Treatment of Alternating Hemiplegia of Childhood.Rescue of Na+ affinity in aspartate 928 mutants of Na+,K+-ATPase by secondary mutation of glutamate 314.Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.Cellular Taxonomy of the Mouse Striatum as Revealed by Single-Cell RNA-Seq.Importance of a Potential Protein Kinase A Phosphorylation Site of Na+,K+-ATPase and Its Interaction Network for Na+ Binding
P2860
Q26741120-D82AE16D-254F-46DB-A13F-035A09E2B1B3Q26744625-8EA0E24B-F009-401F-9000-07D1925A1371Q26746899-BB12F3A3-C1BA-40DA-949F-0A81BC339891Q26747517-35F51EED-4835-45B2-A667-30C3CB896D3EQ26752671-09B8EC5F-154E-41E3-B35D-BC654EFB101EQ27303611-8CA81E24-903A-48A2-B025-145BF86E991DQ27315555-01A8198D-78AB-4518-8765-901EFC4F12C9Q27317321-A4346D0B-F5A4-4E9F-9DF8-8D906B8C169AQ27319517-0C79D2E2-CF78-4128-AB3F-2049202308CBQ28074143-02835732-FCBE-4ECE-94C8-81E93F049A43Q28080503-BF6529D7-7875-42CE-9D42-DF9CD98DF4AFQ28087505-84D3566B-1929-4252-AFFF-8CECAD25D5E7Q28554951-13FC09C1-2FA3-4FE6-9E0F-C260EF232063Q28572007-51D26F73-F411-459D-AB37-0159E3EBCD6BQ30299903-7D4517C5-4D18-46CC-AB05-B7163FB4976FQ30359575-A440B703-7849-4518-9816-A825DC5A712DQ30380725-AD00B402-DAC8-4634-9E0A-0BFADAD4C017Q30840535-8CF530DB-E461-460B-96AD-D055F726F7A3Q33704448-76696A7F-5877-4A3A-BEFE-178B4F90F8DAQ33766129-19987593-F07E-4BA2-8523-EAD8A3C87BFAQ35689799-E993BA95-AF21-4563-B3FA-A578BF99428BQ35964886-D6AFEFA5-5384-4B89-BFFA-84E232F112ADQ36081179-27BD9B80-9F39-4D04-84F3-B5E376B6E2ADQ36094652-0DEE97FD-3B28-4969-8CE3-E527FF183CBFQ36269315-E5DE406A-6B50-4598-A71C-D461A1D8619DQ36470372-C24A7F59-51F5-4422-BC84-77B1EF38E3FCQ36854796-BE55F95F-01EA-480A-B5DF-29D92E36ACD5Q36864425-D9CD6B48-509B-4BC5-A9BC-B03C3D4098C5Q37260425-3616EB1E-DC30-4C3A-9C38-5F2D78EE37C7Q38308429-EA354AA6-40F7-46C0-9C5D-46C28AABFECEQ38336151-456AB1B5-D132-4924-BCEE-E98FF5016C1AQ38493644-BE972BC7-46F4-4D73-98EA-C64220318CCAQ38723250-40FF4F8B-727F-4A56-9DB9-4D979EAC3082Q38728226-1C4D06C7-641F-45F6-9E70-49E1C4BE46BEQ39021644-58DBB8D5-761E-4598-BFD0-4017A91BD455Q39197876-6918D681-204E-48D6-9431-E6D8EFA6E9FDQ39476257-8D212CD2-7405-4A07-BBB2-B289E7B8F362Q40138002-A61E4BA7-D6D3-4FD4-A405-B1E02CC97248Q41335062-FD2D6332-B068-40A8-BB44-A3031EB2C305Q41511630-ACFA4F5F-3B29-4413-9312-FF8B1BC9C3D1
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Distinct neurological disorders with ATP1A3 mutations
@ast
Distinct neurological disorders with ATP1A3 mutations
@en
Distinct neurological disorders with ATP1A3 mutations
@nl
type
label
Distinct neurological disorders with ATP1A3 mutations
@ast
Distinct neurological disorders with ATP1A3 mutations
@en
Distinct neurological disorders with ATP1A3 mutations
@nl
prefLabel
Distinct neurological disorders with ATP1A3 mutations
@ast
Distinct neurological disorders with ATP1A3 mutations
@en
Distinct neurological disorders with ATP1A3 mutations
@nl
P2093
P2860
P50
P1433
P1476
Distinct neurological disorders with ATP1A3 mutations
@en
P2093
ATP1A3 Working Group
Allison Brashear
Arn van den Maagdenberg
Bente Vilsen
Brian Neville
David B Goldstein
Erin L Heinzen
Hanne Poulsen
Kathleen J Sweadner
Laurie J Ozelius
P2860
P304
P356
10.1016/S1474-4422(14)70011-0
P577
2014-05-01T00:00:00Z